Supernus Pharmaceuticals boosts CEO and executive compensation, grants equity

SUPERNUS PHARMACEUTICALS, INC.

CEO Jack Khattar salary raised to $1,001,500; 2023 bonus of $830,588; options for 322,000 shares.
CFO Timothy Dec salary raised to $485,500; 2023 bonus of $210,558; options for 50,000 shares plus RSUs/PSUs.
Four other officers (Bhatt, Rubin, Martin, Mottola) received salary increases and equity awards.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.